After a record number of emergency use products were approved during the Covid-19 pandemic, the US Food and Drug Administration has since started to scale down. ECRI CEO Dr. Marcus Schabacker said that as the agency revokes more authorizations, hospitals should pay close attention to if they continue to use these products, they may be held liable.
He said: “During the pandemic, doctors are desperate to get something.” “If you take (that device), what will they use instead? The hospital must take this into account.”
Just as the FDA grants emergency use authorizations (EUAs) to hundreds of products, it must now go through a time-consuming process to decide which products to approve and which products to stop using. He expects that the agency will consider four main issues when dealing with each issue:
- Is there an FDA-approved substitute for this device?
- Do we really need it anymore?
- Are there any adverse events related to this device?
- What data does the company provide in terms of safety and effectiveness?
For example, the equipment authorized last year could solve the general shortage of protective equipment, but it is no longer needed. In June, the FDA revoked the authorization of the decontamination system used by hospitals to disinfect N95 masks for reuse.Now, the FDA recommends Keep away from disinfecting disposable masks.
Similarly, the agency has cancelled some products that are no longer in use.Last month, it Revoke authorization Covid-19 test for Curative development.The startup’s testing is managed to Hundreds of thousands in Los Angeles, Until FDA Warning false negatives. Now it offers tests developed by Abbott.
“All they are going through now is to see which of these devices are really good or necessary,” Shabak said in an interview with MedCity News.
For healthcare providers, it is their responsibility to ensure that these revoked devices are no longer used.
“People need to take this matter as seriously as they treat a recall,” he said. “If the FDA recalls a product, everyone is responsible for ensuring that it is removed and not used for patients. You can’t let it go here.”
He suggested that the hospital set up a committee to track all the products they are using under the EUA, including a list of their location and supply. He also suggested that they start to consider whether there are approved alternatives and what their plans are if the EUA is revoked.
When this happened, Schabacker said the hospital should move it to a safe area and put a large label on it that read “Not for human use.” If the device is currently being used to treat patients, such as a ventilator, they can complete the treatment first.
During the pandemic, doctors must also deal with changing regulations regarding drugs authorized to treat Covid-19. For example, FDA Withdraw its EUA After determining that they are unlikely to be effective in treating Covid-19, the antimalarial drugs chloroquine and hydroxychloroquine were evaluated in June. Any prescriptions that use them to treat Covid-19 will be off-label and will be accompanied by related responsibilities.
Photo Credit: FDA, Flicker
